Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BeiGene
BeiGene
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
Wed, 11/27/19 - 12:39 pm
FDA
Vertex Pharmaceuticals
Trikafta
Novartis
Adakveo
Alnylam
Givlaari
BeiGene
Brukinsa
Global Blood Therapeutics
Oxbryta
drug approvals
China's BeiGene gets FDA approval for drug to treat rare form of lymphoma
Yahoo/Reuters
Thu, 11/14/19 - 07:27 pm
BeiGene
China
FDA
Brukinsa
mantle cell lymphoma
Ahead of FDA decision on BTK drug, Amgen-partnered BeiGene scores China OK for PD-1
Endpoints
Wed, 11/13/19 - 10:03 am
China
BeiGene
Amgen
tislelizumab
anti-PD-L1
Amgen pays $2.7bn to harness BeiGene’s China marketing muscle
Pharmaforum
Fri, 11/1/19 - 10:26 am
Amgen
China
BeiGene
BeiGene's first U.S. NDA tests global development strategy
BioCentury
Sat, 08/24/19 - 11:06 am
BeiGene
China
FDA
drug development
zanubrutinib
The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)
Yahoo/Motley Fool
Fri, 06/28/19 - 10:14 am
Bristol-Myers Squibb
Celgene
M&A
BeiGene
tislelizumab
Otezla
As Bristol-Myers/Celgene tie up loose ends, BeiGene pockets $150M from PD-1 breakup
Endpoints
Mon, 06/17/19 - 10:06 am
BeiGene
Bristol-Myers Squibb
Celgene
Opdivo
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
Upcoming events – Crucial data on zanubrutinib and filgotinib approach
EP Vantage
Fri, 06/14/19 - 10:14 am
BeiGene
Waldenström’s macroglobulinemia
zanubrutinib
Galapagos
filgotinib
CLE
Sjögren’s syndrome
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Following key late-stage advances, BeiGene puts down $10M to get some discovery projects rolling at Ambrx
Endpoints
Wed, 03/6/19 - 10:10 am
BeiGene
China
Ambrx
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
M&A
Bristol-Myers Squibb
Celgene
Vividion Therapeutics
Evotec
Prothena
Anokion
Skyhawk Therapeutics
Dragonfly Therapeutics
BeiGene
Agios Pharmaceuticals
Jounce Therapeutics
In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica
Endpoints
Tue, 01/15/19 - 10:08 am
China
FDA
Btk inhibitors
BeiGene
cancer
BMS deal weighs on Celgene partners
BioCentury
Thu, 01/3/19 - 11:45 pm
M&A
Celgene
Bristol-Myers Squibb
Acceleron
BeiGene
BeiGene bags Asian rights to Zymeworks’ HER2 bispecifics
Fierce Biotech
Tue, 11/27/18 - 11:32 pm
BeiGene
Zymeworks
bispecific antibodies
ZW25
ZW49
BeiGene Announces Acceptance of its NDA in China for Zanubrutinib in Certain Types of Leukemia and Lymphoma
Wed, 10/24/18 - 11:53 am
BeiGene
zanubrutinib
BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors
CP Wire
Mon, 10/22/18 - 10:43 am
BeiGene
pamiparib
solid tumors
BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors
Mon, 10/22/18 - 10:01 am
BeiGene
pamiparib
BeiGene Presents Encouraging Results in Ph I Trial of Tislelizumab in Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors
Thu, 09/20/18 - 09:47 am
BeiGene
tislelizumab
Hong Kong could become biotech listing hub, says BeiGene boss as Chinese drug maker gears up for US$1 billion flotation
South China Morning Post
Mon, 07/30/18 - 11:12 am
Hong Kong
BeiGene
China
biotech
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »